Beijing reported its second consecutive day of record numbers of virus cases and hospitalisations rose in some U.S. states, leading investors to reassess their assumption of a swift V-shaped recovery.
“I am convinced that if cases continue to rise again, market participants will clearly re-evaluate market valuations and their assumptions”, said Stephane Ekolo, an equity strategist at TFS Derivatives in London.
“Market are pricing a too-optimistic recovery, in my opinion, and there could be a reality check coming rather sooner than later”, he said.
The pan-European STOXX 600 fell 2.5% with all sectors and regional markets trading deep in the red after losses accelerated in the final hours of trading in Asia.
Earlier, Japan’s Nikkei fell 3.5% and South Korean shares tumbled 4.8%.
Futures for the S&P 500 also extended losses, shedding 2.9%.
The retreats follows a global rally since late March, fuelled by central bank and fiscal stimulus and optimism about countries gradually lifting the lockdowns implemented to stop the spread of the novel coronavirus.
A number of analysts, however, have warned about a possible disconnect between anticipation of a dire global recession and the optimism in stock markets, with the Nasdaq hitting record highs even though U.S. unemployment has surged.
Euro zone bond yields edged down as investors bought safer assets such as government bonds.
Germany’s 10-year bond yield was near a three-week lows at -0.46%.
Brent crude futures fell 2.7%, to $37.69 a barrel. U.S. West Texas Intermediate crude futures were down 4.1%, to $34.78 a barrel.
Oil investors await OPEC+ committee meetings later this week that will advise the producer group and its allies on output cuts.
In currencies, the dollar index index rose to 97.27, flirting with a 10-day high, while risk-sensitive currencies such as the Norwegian and Swedish crowns suffered, trading around two-weeks lows.
The euro slipped 0.1% versus the dollar at $1.1243
Worldwide coronavirus cases have crossed 7.86 million with 430,501 deaths, according to a Reuters tally.
More about: COVID-19 second-wave
